Category: Quotation
|
|
| |
|
California Life Science Firms to Learn "Insider" Strategies for Government Funding at 11th SoCalBio Investor & Partnership Conference
|
 |
Firms Offer EBC Companies Access to Leading Design Software to Speed Time to Market for Clean Energy and Environmental Technologies
SAN JOSE and SAN RAFAEL, Calif., July 13, 2010 — Autodesk, Inc. (NASDAQ: ADSK) and the Environmental Business Cluster (EBC) have forged an industry partnership to offer benefits of the Autodesk Clean Tech Partner Program to the EBC community so companies can innovate and commercialize their ideas more quickly.
EBC is an award-winning clean tech incubator in Silicon Valley that provides commercialization support and facilities for emerging clean energy and environmental technology companies. The Autodesk Clean Tech Partner Program provides Digital Prototyping software to clean technology companies to enable them to digitally design, visualize and simulate the real-world performance of products before they are built. Creation of digital prototypes can serve as a catalyst to help participants secure financing and effectively market their ideas.
Participation comes from academic institutions and companies across the state
Waltham, Massachusetts - The Massachusetts Life Sciences Center’s 2010 Internship Challenge has received an overwhelming response since its February launch, with nearly 900 applicants seeking internships this summer. Over 130 companies from all sectors of the life sciences community have combed through hundreds of resumes, held numerous interviews, and selected interns to hire. Through the Challenge, 164 interns have been matched with 93 life sciences companies, a more than 50% increase from the 104 interns selected in 2009.
The Massachusetts Life Sciences Center’s Internship Challenge is a workforce development program focused on enhancing the talent pipeline for life sciences companies in Massachusetts while providing interns with practical, “hands on” experience that prepares them to step into the workforce ready to meet the job requirements of life sciences employers. The program is providing paid summer internships to undergraduates, graduate students, and recent college graduates from 46 different colleges and universities.
Center will provide $2.48 million to support four early-stage life sciences companies
Waltham, MA – The Massachusetts Life Sciences Center (the “Center”), a quasi-public agency tasked with implementing the state’s ten-year, $1 billion Life Sciences Initiative, today announced the awarding of $2.48 million in loans to four early-stage life sciences companies. The Center’s Accelerator Program provides loans of up to $750,000 to early-stage companies engaged in life sciences research and development, commercialization and manufacturing. The Center’s Board of Directors approved the first round of 2010 Accelerator loans today. Four companies were authorized to receive loans out of thirty-nine applications that were submitted to the Center and competitively peer-reviewed. A second round of the Program is scheduled for the Fall of 2010.
At two-year mark, state’s Life Sciences Initiative provides strong return on investment
Waltham, MA – The Massachusetts Life Sciences Center is providing a $50,000 grant to the Massachusetts Life Sciences Collaborative to support an initiative aimed at strengthening the state’s biomanufacturing sector through a Massachusetts Biomanufacturing Roundtable and the development of a comprehensive Biomanufacturing action agenda during the 2010 calendar year. The Biomanufacturing Roundtable includes participation from influential life sciences, biomanufacturing, academic, and government leaders, including Massachusetts Life Sciences Center President & CEO, Dr. Susan Windham-Bannister. The Roundtable is co-chaired by Taligen Therapeutics CEO Abbie Celniker, Acceleron Pharma Senior Vice President of Manufacturing Bob Steininger, and former Pfizer Vice President Mickey Koplove.
Application period opens on June 21st
Contact: Angus G. McQuilken, MLSC VP for Communications
Boston, MA – Governor Patrick, the Massachusetts Life Sciences Center, MassBio and MassMEDIC today urged qualifying companies to apply for the Therapeutic Discovery Tax Credit, a new federal program created under the Affordable Care Act to support biomedical research. Qualifying companies may apply to the new federal program starting on Monday, June 21, 2010 with applications due by July 21, 2010. Applicants will receive a determination no later than October 29, 2010. More information is available on the web site of the Massachusetts Life Sciences Center, www.masslifescience.com.
Massachusetts Life Sciences Center co-sponsors contest and contributes to prize
Cambridge, MA - Aukera Therapeutics has been named the 2010 MIT $100K Entrepreneurship Competition Life Sciences Track Winner. Aukera also won the Audience Choice Award, based on voting by the 1,000 attendees at the Competition’s finale. The company will receive $30,000 in start-up funding from the competition. Also receiving awards were runner-up Invitronix ($5,000) and second runner-up Hydrangle Systems ($3,000). The Massachusetts Life Sciences Center, the agency charged with implementing the State’s 10-year, $1 billion Life Sciences Initiative, contributed $10,000 to support the life sciences track. The Cambridge Innovation Center will be providing the finalists with in-kind support, including workspace.
Grants Will Help Bring New Green Technologies to Market, Creating Jobs, Launching Businesses
Philadelphia, June 11, 2010- The City of Philadelphia and the Philadelphia Industrial Development Corporation, in partnership with the Ben Franklin Technology Partners of Southeastern PA are launching an innovative new pilot program designed to help Philadelphia companies with cutting edge energy efficiency technologies develop a market for their products. The Greenworks Pilot Energy Technology (G-PET) Program offers grants to Philadelphia companies to accelerate the introduction of their new, energy efficient products and services to the marketplace. G-PET is being funded with $430,000 of federal Energy Efficiency and Conservation Block Grant funding under the American Recovery and Reinvestment Act of 2009 to the City of Philadelphia.
Center Awards $1.5 million to foster job growth and technology commercialization in the Massachusetts Life Sciences Supercluster
For Immediate Release: Date: May 28, 2010
Contact: Angus G. McQuilken, MLSC VP for Communications
Phone: (617) 921-7749 Email: amcquilken@masslifesciences.com
“This is all about jobs. By helping life sciences companies grow, we create new opportunities for people to work,” said Governor Deval Patrick. “As we continue to strengthen our global leadership in the life sciences, this program will meet an important need and make Massachusetts an even more attractive place for life sciences companies to locate and grow.”
Waltham, MA – The Massachusetts Life Sciences Center’s Board of Directors today awarded $1.5 million in Small Business Matching Grants to three life sciences companies in Massachusetts. The companies receiving grants are Boston Biochem Inc. and Tetragenetics Inc., both of Cambridge and Thermedical Inc. of Somerville. Each company will receive $500,000 from the Center to match federal small business grant funding that the companies had previously been awarded. The grants represent the first round of awards issued under the Center’s Small Business Matching Grant (SBMG) Program. The three companies that are receiving awards have committed to collectively creating 40 new jobs in the Commonwealth by the end of 2011, including six jobs to be relocated from New York.
The Center’s Small Business Matching Grant Program, launched in January 2010 as part of the state’s ten-year, $1 billion Life Sciences Initiative, will match federal small business grant funding for early-stage life sciences companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. Goals of the program include the creation of jobs in Massachusetts by the commercialization of products with high potential for market adoption and penetration.
Albuquerque, NM (June 2,2010)- Cancer diagnostics company Biomoda, Inc. (OTC BB:BMOD) (www.biomoda.com) and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding (MOU) to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda’s porphyrin-based assay for the detection of early-stage cancer.
The Clinical Laboratory Improvement Amendments (CLIA) were passed by congress in 1988 to establish standards for laboratory testing and ensure the accuracy and reliability of patient test results. Laboratories that meet CLIA standards are certified by the U.S. Department of Health and Human Services.
